MA
PIIIW icon

MYDA Advisors’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

MYDA Advisors’s Portfolio PIIIW Stock Details PIIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,000
Closed -$30K – 254
2021
Q4 		$30K Buy
+29,000
New +$35.1K 0.01% 238

Other funds holding PIIIW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

MYDA Advisors's PIIIW Position: Q1 2022 in Review

MYDA Advisors sold out of P3 Health Partners Inc Warrant (PIIIW) in Q1 2022, closing a stake of 29,000 shares — an estimated $30K sold.

MYDA Advisors first reported a position in PIIIW in Q4 2021 and held it in 1 quarter. The position peaked at $30K in Q4 2021. 29 funds tracked by Wall St. Rank hold PIIIW as of Q1 2022.

  • MYDA Advisors reported no remaining P3 Health Partners Inc Warrant position as of Q1 2022 after selling out during the quarter.
  • MYDA Advisors sold 29,000 P3 Health Partners Inc Warrant shares in Q1 2022, an estimated $30K.
  • MYDA Advisors first reported a position in P3 Health Partners Inc Warrant in Q4 2021 and held it in 1 quarter.
  • MYDA Advisors's P3 Health Partners Inc Warrant position peaked at $30K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q1 2022.

Based on MYDA Advisors's 13F filing for Q1 2022, filed 13 May 2022.